TENAX THERAPEUTICS, INC. — Director's Dealing 2010

Jun 15, 2010

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: OXYGEN BIOTHERAPEUTICS, INC. (OXBT)
CIK: 0000034956
Period of Report: 2010-04-30

Reporting Person: Stern Christian J (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-03	Common Shares	P	529	$5	Acquired	31425	Direct
2010-03-05	Common Stock	P	587	$5.15	Acquired	31425	Direct
2010-03-15	Common Stock	P	12543	$5.1	Acquired	31425	Direct
2010-04-21	Common Stock	P	570	$5	Acquired	31425	Direct